CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Venclose RF Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04236245
NCT04236245N/ACompleted
CompareCT.gov

EU Post Market Clinical Follow-Up Study of the Venclose System for Saphenous Vein Incompetence

Venclose, Inc.·interventional·Posted Jan 22, 2020·Updated Apr 4, 2022

In Brief

A clinical study evaluating Venclose RF System for Chronic Venous Insufficiency. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This is a prospective, non-randomized study in which patients who meet eligibility criteria and consent to participate will undergo a minimally invasive procedure using radiofrequency (RF) energy for ablation of the great saphenous vein (GSV).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Venous Insufficiency
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 22, 2020
Enrollment StartMay 11, 2020
Primary CompletionAug 2, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.4 years ago

Interventions

Venclose RF Systemdevice

Treatment of great saphenous vein (GSV) using Venclose RF System